TAK-715

DB16108InvestigationalSmall molecule

TAK-715 is under investigation in clinical trial NCT00760864 (Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis).

Mechanism: Pharmacologically active on Mitogen-activated protein kinase 14
Curator reviewed
Formula / weight: C₂₄H₂₁N₃OS · 399.51 g/mol (avg)
Code names: TAK-715

Resolves to

Compound

Structure

InChIKeyHEKAIDKUDLCBRU-UHFFFAOYSA-NSMILESCCC1=NC(=C(S1)C1=CC(NC(=O)C2=CC=CC=C2)=NC=C1)C1=CC=CC(C)=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with TAK-715, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.